Company Profile
Business Description
We are a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological disease. Our zinc finger epigenetic regulators are ideally suited to potentially address devastating neurology disorders and our capsid discovery platform is making progress toward potentially expanding delivery beyond currently available intrathecal delivery capsids, including in the central nervous system.
Headquarters
501 Canal Blvd, Richmond, CA 94804
Industry Classifications
Sector
Healthcare
Industry
Biotechnology
NAICS
Biological Product (Except Diagnostic) Manufacturing (325414)
SIC
Biological Products, Except Diagnostic Substances (2836)
Stock Information
Stock Chart
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Historical Lookup
Week of April 29, 2024
| Date Requested | Closing Price | Volume | Split Adjustment Factor | Open Price | Day High | Day Low |
|---|---|---|---|---|---|---|
| April 29, 2024 | $0.52 | 968,787 | 1:1 | $0.52 | $0.54 | $0.50 |